Adverse events (AEs) with maintenance olaparib tablets in patients (pts) with BRCA-mutated (BRCAm) platinum-sensitive relapsed serous ovarian cancer (PSR SOC): Phase III SOLO2 trial

Jonathan A. Ledermann; Alain Lortholary; Richard T. Penson; Emma Gibbs; Diane M. Provencher; Ilan Bruchim; Tomas Huzarski; Maria Pilar Barretina-Ginesta; Roberto Sabbatini; Linda R. Mileshkin; Nicoletta Colombo; Tjoung-Won Park-Simon; Koji Matsumoto; Gabe S. Sonke; Olga N. Mikheeva; Jae-Weon Kim; Gustavo Colagiovanni Girotto; Hannelore Denys; Elizabeth S. Lowe; Eric Pujade-Lauraine

doi:10.1200/JCO.2017.35.15_suppl.5518

Adverse events (AEs) with maintenance olaparib tablets in patients (pts) with BRCA-mutated (BRCAm) platinum-sensitive relapsed serous ovarian cancer (PSR SOC): Phase III SOLO2 trial

Jonathan A. Ledermann, Alain Lortholary, Richard T. Penson, Emma Gibbs, Diane M. Provencher, Ilan Bruchim, Tomas Huzarski, Maria Pilar Barretina-Ginesta, Roberto Sabbatini, Linda R. Mileshkin, Nicoletta Colombo, Tjoung-Won Park-Simon, Koji Matsumoto, Gabe S. Sonke, Olga N. Mikheeva, Jae-Weon Kim, Gustavo Colagiovanni Girotto, Hannelore Denys, Elizabeth S. Lowe, Eric Pujade-Lauraine

Medicine

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Journal	Journal of Clinical Oncology
Volume	35
DOIs	https://doi.org/10.1200/JCO.2017.35.15_suppl.5518
State	Published - 20 May 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/JCO.2017.35.15_suppl.5518

Cite this

Ledermann, J. A., Lortholary, A., Penson, R. T., Gibbs, E., Provencher, D. M., Bruchim, I., Huzarski, T., Barretina-Ginesta, M. P., Sabbatini, R., Mileshkin, L. R., Colombo, N., Park-Simon, T.-W., Matsumoto, K., Sonke, G. S., Mikheeva, O. N., Kim, J.-W., Girotto, G. C., Denys, H., Lowe, E. S., & Pujade-Lauraine, E. (2017). Adverse events (AEs) with maintenance olaparib tablets in patients (pts) with BRCA-mutated (BRCAm) platinum-sensitive relapsed serous ovarian cancer (PSR SOC): Phase III SOLO2 trial. Journal of Clinical Oncology, 35. https://doi.org/10.1200/JCO.2017.35.15_suppl.5518

@article{c7c03e77ca3942afaa7904f74f849aea,

title = "Adverse events (AEs) with maintenance olaparib tablets in patients (pts) with BRCA-mutated (BRCAm) platinum-sensitive relapsed serous ovarian cancer (PSR SOC): Phase III SOLO2 trial",

author = "Ledermann, {Jonathan A.} and Alain Lortholary and Penson, {Richard T.} and Emma Gibbs and Provencher, {Diane M.} and Ilan Bruchim and Tomas Huzarski and Barretina-Ginesta, {Maria Pilar} and Roberto Sabbatini and Mileshkin, {Linda R.} and Nicoletta Colombo and Tjoung-Won Park-Simon and Koji Matsumoto and Sonke, {Gabe S.} and Mikheeva, {Olga N.} and Jae-Weon Kim and Girotto, {Gustavo Colagiovanni} and Hannelore Denys and Lowe, {Elizabeth S.} and Eric Pujade-Lauraine",

year = "2017",

month = may,

day = "20",

doi = "10.1200/JCO.2017.35.15_suppl.5518",

language = "אנגלית",

volume = "35",

}

Ledermann, JA, Lortholary, A, Penson, RT, Gibbs, E, Provencher, DM, Bruchim, I, Huzarski, T, Barretina-Ginesta, MP, Sabbatini, R, Mileshkin, LR, Colombo, N, Park-Simon, T-W, Matsumoto, K, Sonke, GS, Mikheeva, ON, Kim, J-W, Girotto, GC, Denys, H, Lowe, ES & Pujade-Lauraine, E 2017, 'Adverse events (AEs) with maintenance olaparib tablets in patients (pts) with BRCA-mutated (BRCAm) platinum-sensitive relapsed serous ovarian cancer (PSR SOC): Phase III SOLO2 trial', Journal of Clinical Oncology, vol. 35. https://doi.org/10.1200/JCO.2017.35.15_suppl.5518

Adverse events (AEs) with maintenance olaparib tablets in patients (pts) with BRCA-mutated (BRCAm) platinum-sensitive relapsed serous ovarian cancer (PSR SOC): Phase III SOLO2 trial. / Ledermann, Jonathan A.; Lortholary, Alain; Penson, Richard T. et al.
In: Journal of Clinical Oncology, Vol. 35, 20.05.2017.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Adverse events (AEs) with maintenance olaparib tablets in patients (pts) with BRCA-mutated (BRCAm) platinum-sensitive relapsed serous ovarian cancer (PSR SOC): Phase III SOLO2 trial

AU - Ledermann, Jonathan A.

AU - Lortholary, Alain

AU - Penson, Richard T.

AU - Gibbs, Emma

AU - Provencher, Diane M.

AU - Bruchim, Ilan

AU - Huzarski, Tomas

AU - Barretina-Ginesta, Maria Pilar

AU - Sabbatini, Roberto

AU - Mileshkin, Linda R.

AU - Colombo, Nicoletta

AU - Park-Simon, Tjoung-Won

AU - Matsumoto, Koji

AU - Sonke, Gabe S.

AU - Mikheeva, Olga N.

AU - Kim, Jae-Weon

AU - Girotto, Gustavo Colagiovanni

AU - Denys, Hannelore

AU - Lowe, Elizabeth S.

AU - Pujade-Lauraine, Eric

PY - 2017/5/20

Y1 - 2017/5/20

U2 - 10.1200/JCO.2017.35.15_suppl.5518

DO - 10.1200/JCO.2017.35.15_suppl.5518

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.abstract???

SN - 0732-183X

VL - 35

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -